drugset / Trial / NCT06680089
CD70-targeted immunoPET Imaging of Kidney Cancer
NaSingle-groupOpen-labelDiagnostic
Summary
The aim of this study is to establish and optimize the \[18F\]RCCB6 PET/CT imaging method, and its physiological and pathological distribution characteristics, on the basis of which the diagnostic efficacy of the above imaging agent in renal cancer (especially clear cell renal cell carcinoma) wil be evaluated.
Timeline
- Start
- 2024-11-27
- Primary completion
- 2026-11
- Completion
- 2027-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [18F]RCCB6 | Diagnostic / imaging agent | 1.85 mbq/kg | — |
| Subject | [18F]RCCB6 | Diagnostic / imaging agent | 3.7 mbq/kg | — |